Under the deal, Medicare and Medicaid will pay $245 a month for weight loss medications including Ozempic, Wegovy, Mounjaro and Zepbound, and older Americans who qualify will pay a $50 monthly co-pay
Originally developed to treat type 2 diabetes, these medications are now also making headlines for their possible effects on heart health
J Pest Sci
Months 2-3: Many people lose 5-10% of their starting weight

CrossRef Characteristics of serum bile acid profiles among individuals with metabolic dysfunction-associated steatotic liver disease Sheng Lyu, Jiani Yang, Xin Xin, Qinmei Sun, Beiyu Cai, Xin Wang, Ziming An, Jian Sun, Yiyang Hu, Lei Shi, Qin Feng, Xiaojun Gou BMC Gastroenterology .2025;[Epub] CrossRef Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies Claudia Reytor-Gonzlez, Daniel Simancas-Racines, Martn Campuzano-Donoso, Janeth Castano Jimenez, Nthaly Mercedes Romn-Galeano, Gerardo Sarno, Evelyn Frias-Toral Food and Agricultural Immunology .2025;[Epub] CrossRef Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 20012018 Zhengjin Wang, Zhangxin Chen, Hanxu Zhuang Frontiers in Nutrition .2025;[Epub] CrossRef Anthropometric Measures and Mortality Risk in Individuals With Metabolic DysfunctionAssociated Steatotic Liver Disease (MASLD): A PopulationBased Cohort Study Yee Hui Yeo, Yixuan Zhu, Jingli Gao, Shanghao Liu, Wenjing Ni, Fajuan Rui, Xue Bai, Nan Geng, Rui Jin, Elizabeth K

a second afternoon dose extends coverage